Performance of a Continuous Glucose Monitoring System During Controlled Hypoglycaemia in Healthy Volunteers
Authors:
- 1 October 2002
- journal article
- research article
- Published by SAGE Publications in Diabetes Technology & Therapeutics
- Vol. 4 (5) , 607-613
Abstract
It has been suggested that the continuous glucose monitoring system may be a useful tool for detecting unrecognised hypoglycaemia, especially at times when finger prick testing is difficult or impossible (e.g., at night). Studies suggest that subcutaneous glucose levels closely mimic blood glucose levels with a lag time of only a few minutes. However, no studies have been published to show how well the sensor performs during sustained or in recovery from hypoglycaemia. This study involved using a hyperinsulinaemic glucose clamp (60 mU/m2) in nine healthy volunteers. Each subject had two sensors inserted the day before the study. Blood glucose levels were maintained at euglycaemia for the first 60 min, then decreased to 45 mg/dL (2.5 mmol/L) for 60 min, and finally restored to euglycaemia. Blood glucose measurements were compared with interstitial values recorded by the sensor. Sensor profiles showed acceptable agreement with blood glucose levels at each of the three plateaus with a correlation coefficient of 0.79, slope of 0.85, and mean absolute error of 7%. The sensor drop closely matched the drop in blood glucose, but the recovery from hypoglycaemia was delayed by an average of 26 min. Continuous glucose sensing provides a useful means of detecting unrecognised hypoglycaemia in type 1 diabetes, although the duration of hypoglycaemia may be overestimated.Keywords
This publication has 4 references indexed in Scilit:
- A Pilot Study of the Continuous Glucose Monitoring SystemDiabetes Care, 2001
- Limitations of Conventional Methods of Self-Monitoring of Blood GlucoseDiabetes Care, 2001
- Continuous Subcutaneous Glucose Monitoring in Children With Type 1 DiabetesPediatrics, 2001
- Continuous glucose monitoring used to adjust diabetes therapy improves glycosylated hemoglobin: a pilot studyDiabetes Research and Clinical Practice, 1999